Quantum Biopharma (QNTM) Other Working Capital Changes (2019 - 2026)
Quantum Biopharma (QNTM) reported Other Working Capital Changes of -$60893.0 for Q1 2026, up 19.14% on a YoY basis from -$51109.4 in Q1 2025, and down 353.68% sequentially from $24004.0 in Q4 2025.
Quantum Biopharma (QNTM) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Other Working Capital Changes data on file, last reported at -$60893.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 19.14% year-over-year to -$60893.0; the trailing twelve-month figure through Mar 2026 stood at $68162.0 (down 47.06% YoY), and the FY2025 full-year result was $53746.0, down 37.78% from the prior year.
- Other Working Capital Changes declined to -$60893.0 in Q1 2026, from $24004.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $584306.0 in Q4 2022 to a low of -$365403.0 in Q1 2023.
- A 5-year average of $70110.8 and a median of $38862.0 in 2022 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 2179.95% in 2025, while the deepest fall reached 316.5% in 2025.
- Tracing QNTM's Other Working Capital Changes over 5 years: stood at $584306.0 in 2022, then slumped by 66.98% to $192953.0 in 2023, then plunged by 57.87% to $81289.0 in 2024, then plunged by 70.47% to $24004.0 in 2025, then sank by 353.68% to -$60893.0 in 2026.
- Business Quant data shows QNTM's Other Working Capital Changes at -$60893.0 in Q1 2026, $24004.0 in Q4 2025, and $413930.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Quantum Biopharma | 2.61 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60,893.00 |
| Mar 31, 2026 | -60,893.00 |
| Mar 31, 2026 | -60,893.00 |
| Dec 31, 2025 | 24,004.00 |
| Dec 31, 2025 | 24,004.00 |
| Dec 31, 2025 | 24,004.00 |
| Sep 30, 2025 | 413,930.00 |
| Sep 30, 2025 | 413,930.00 |
| Sep 30, 2025 | 413,930.00 |
| Jun 30, 2025 | -308,879.00 |
| Jun 30, 2025 | -308,879.00 |
| Jun 30, 2025 | -308,879.00 |
| Mar 31, 2025 | -75,309.00 |
| Mar 31, 2025 | -75,309.00 |
| Mar 31, 2025 | -75,309.00 |
| Dec 31, 2024 | 81,289.00 |
| Dec 31, 2024 | 81,289.00 |
| Dec 31, 2024 | 81,289.00 |
| Sep 30, 2024 | -19,901.00 |
| Sep 30, 2024 | -19,901.00 |